Background: Implantable cardioverter‐defibrillators (ICDs) reduce the rate of sudden cardiac
death (SCD) in patients with cardiomyopathy and reduced left ventricular systolic function. It …

Aims In elderly patients, obscurity remains regarding the benefit of implantable cardioverter–
defibrillator (ICD) treatment as primary prevention of sudden cardiac death. This study …

Aims Currently, there continues to be a lack of evidence regarding outcomes associated with
device-based therapy for ventricular arrhythmias in elderly patients, even more in primary …

Background: Randomized clinical trials (RCTs) have demonstrated the efficacy of
implantable cardioverter-defibrillators (ICDs) in reducing sudden cardiac death (SCD) in …

Background Implantable cardioverter-defibrillator (ICD) therapy is well established for
secondary prevention, but studies on the efficacy and safety in elderly patients are still …

Aims Current guidelines do not propose any age cut-off for the primary prevention
implantable cardioverter-defibrillator (ICD). However, the risk/benefit balance in the very …

Aging is associated with structural alterations in the heart that predispose the elderly to life‐
threatening ventricular arrhythmias. The majority of sudden cardiac deaths occur in people …

The incidence of sudden cardiac death increases with age and the proportion of the US
population in progressively more advanced age strata is dramatically increasing. While …

Background The benefit of implantable cardioverter‐defibrillator (ICD) in elderly patients has
been questioned. In the present study, we aimed to analyse the outcome of patients of …

Given their advanced age and frequent co-morbidities, it is unclear whether octogenarians
and nonagenarians with decreased left ventricular ejection fraction (LVEF) derive a survival …